Antimicrobial Peptides: From Design to Clinical Application

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Multidrug-resistant (MDR) bacteria, including MRSA, CRE, and ESBL-producing E. coli, pose significant public health and economic challenges.
• Bacterial resistance mechanisms include target mutation, efflux pumps, and enzymatic degradation, limiting current treatment options.
• The urgent need for novel antibacterial agents necessitates exploring alternative therapeutic strategies.

Purpose of the Study:

• To review the mechanisms of antibiotic resistance in pathogenic bacteria.
• To explore the killing mechanisms and therapeutic potential of antimicrobial peptides (AMPs) as alternatives to antibiotics.
• To discuss strategies for designing, optimizing, and delivering AMPs for enhanced antimicrobial efficacy and reduced toxicity.

Main Methods:

• Literature review focusing on antibiotic resistance development and antimicrobial peptide mechanisms.
• Analysis of strategies for AMP design and optimization, including structural modifications and conjugation.
• Summary of recent clinical trials and applications of AMPs within the last five years.

Main Results:

• Antimicrobial peptides (AMPs) exhibit diverse mechanisms against bacterial infections, including direct bactericidal activity and immunomodulatory effects.
• Optimization strategies such as structural changes, amino acid substitutions, and nanoparticle encapsulation can improve AMP efficacy and delivery.
• Recent clinical trials indicate growing potential for AMPs in treating bacterial infections.

Conclusions:

• Antimicrobial peptides (AMPs) represent a viable alternative to conventional antibiotics for combating MDR bacterial infections.
• Further research and clinical investigations are crucial to accelerate the development and application of AMPs.
• Optimized AMPs demonstrate potential for improved treatment outcomes with reduced toxicity and enhanced delivery.